To determine the role of HDAC enzymes and the impact of TGFβ on the metabolic activity of fibroblasts, the HDAC inhibitor VPA was tested in CCD-18Co intestinal fibroblasts and primary CD fibroblasts treated with or without TGFβ. This evidence concerns the gene TGFB1 and Cowden disease.